News Releases

News Releases

Feb 01, 2024
– Guggenheim 6th Annual Biotechnology Conference – – Oppenheimer 34th Annual Healthcare Life Sciences Conference – PRINCETON, N.J. --(BUSINESS WIRE)--Feb. 1, 2024-- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat
Jan 24, 2024
PRINCETON, N.J. --(BUSINESS WIRE)--Jan. 24, 2024-- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today announced the submission of the Chemistry, Manufacturing, and Controls (CMC) section
Jan 11, 2024
- Fireside Chat January 18, 2024 , at 12:00 pm ET - PRINCETON, N.J. --(BUSINESS WIRE)--Jan. 11, 2024-- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that Liz Barrett